Allele frequencies of dopamine D4 receptor gene (DRD4) and Catechol-O-methyltransferase (COMT) Val158Met polymorphism are associated with methylphenidate response in adolescents with attention deficit/hyperactivity disorder: a case control preliminary study

References

• American Psychiatric Association Diagnostic and statistical manual of mental disorders (DSM-5). American Psychiatric Pub 2013.
   Google Scholar
• Polanczyk G, de Lima MS, Horta BL, et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007;164:942–948. doi: 10.1176/ajp.2007.164.6.942
   PubMed Web of Science ®Google Scholar
• Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the national comorbidity survey replication. Am J Psychiatry. 2006;163:716–723. doi: 10.1176/ajp.2006.163.4.716
   PubMed Web of Science ®Google Scholar
• Bobb AJ, Castellanos FX, Addington AM, et al. Molecular genetic studies of ADHD: 1991 to 2004. Am J Med Genet B Neuropsychiatr Genet. 2005;132:109–125.
   Google Scholar
• Kereszturi E, Tarnok Z, Bognar E, et al. Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children. Am J Med Genet Part B: Am J Med Genet. 2008;147B:1431–1435. doi: 10.1002/ajmg.b.30704
   PubMed Web of Science ®Google Scholar
• Roman T, Schmitz M, Polanczyk G, et al. Attention-deficit hyperactivity disorder: A study of association with both the dopamine transporter gene and the dopamine D4 receptor gene. Am J Med Genet. 2001;105:471–478. doi: 10.1002/ajmg.1408
   PubMed Web of Science ®Google Scholar
• Szobot C, Roman T, Cunha R, et al. Brain perfusion and dopaminergic genes in boys with attention-deficit/hyperactivity disorder. Am J Med Genet Part B (Neuropsychiatric Genetics). 2005;132B:53–58. doi: 10.1002/ajmg.b.30096
   PubMed Web of Science ®Google Scholar
• Gizer IR, Waldman ID. Double dissociation between lab measures of inattention and impulsivity and the dopamine transporter gene (DAT1) and dopamine D4 receptor gene (DRD4). J Abnorm Psychol. 2012;121:1011–1023. doi: 10.1037/a0028225
   Web of Science ®Google Scholar
• Noain D, Avale ME, Wedemeyer C, et al. Identification of brain neurons expressing the dopamine D4 receptor gene using bac transgenic mice. Eur J Neurosci. 2006;24:2429–2438. doi: 10.1111/j.1460-9568.2006.05148.x
   PubMed Web of Science ®Google Scholar
• Johnson KA, Kelly SP, Robertson IH, et al. Absence of the 7-repeat variant of the DRD4 VNTR is associated with drifting sustained attention in children with ADHD but not in controls. Am J Med Genet B Neuropsychiatr Genet. 2008;147B:927–937. doi: 10.1002/ajmg.b.30718
   PubMed Web of Science ®Google Scholar
• Kieling C, Roman T, Doyle AE, et al. Association between DRD4 gene and performance of children with ADHD in a test of sustained attention. Biol Psychiatry. 2006;60:1163–1165. doi: 10.1016/j.biopsych.2006.04.027
   Web of Science ®Google Scholar
• Asghari V, Sanyal S, Buchwaldt S, et al. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem. 1995;65:1157–1165. doi: 10.1046/j.1471-4159.1995.65031157.x
   PubMed Web of Science ®Google Scholar
• Faraone SV, Mick E. Molecular genetics of attention deficit hyperactivity disorder. Psychiatr Clin North Am. 2010;33:159–180. doi: 10.1016/j.psc.2009.12.004
   PubMed Web of Science ®Google Scholar
• Tunbridge EM, Harrison PJ, Weinberger DR. Catechol-O-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry. 2006;60(2):141–151. doi: 10.1016/j.biopsych.2005.10.024
   PubMed Web of Science ®Google Scholar
• Egan MF, Goldberg TE, Kolachana BS, et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA. 2001;98(12):6917–6922. doi: 10.1073/pnas.111134598
   PubMed Web of Science ®Google Scholar
• Winterer G, Egan MF, Kolachana BS, et al. Prefrontal electrophysiologic ‘noise’ and catechol-O-methyltransferase genotype in schizophrenia. Biol Psychiatry. 2006;60(6):578–584. doi: 10.1016/j.biopsych.2006.03.023
   Web of Science ®Google Scholar
• Karayiorgou M, Gogos JA, Galke BL, et al. Identification of sequence variants and analysis of the role of the catechol-O-methyl-transferase gene in schizophrenia susceptibility. Biol Psychiatry. 1998;43(6):425–431. doi: 10.1016/S0006-3223(97)00202-3
   Web of Science ®Google Scholar
• Kotler M, Barak P, Cohen H, et al. Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activity. Am J Med Genet. 1999;88(6):628–633. doi: 10.1002/(SICI)1096-8628(19991215)88:6<628::AID-AJMG10>3.0.CO;2-E
   PubMed Web of Science ®Google Scholar
• Faraone, SV, Biederman, J. Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry. 1998;44(10):951–958. doi: 10.1016/S0006-3223(98)00240-6
   PubMed Web of Science ®Google Scholar
• Barr CL, Xu C, Kroft J, et al. Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder. Biol Psychiatry. 2001;49(4):333–339. doi: 10.1016/S0006-3223(00)01053-2
   PubMed Web of Science ®Google Scholar
• LaHoste GJ, Swanson JM, Wigal SB, et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry. 1996;1(2):121–124.
   PubMed Web of Science ®Google Scholar
• Cook EJ, Stein MA, Krasowski MD, et al. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet. 1995;56(4):993–998.
   PubMed Web of Science ®Google Scholar
• Faraone SV, Biederman J, Chen WJ, et al. Genetic heterogeneity in attention-deficit hyperactivity disorder (ADHD): gender, psychiatric comorbidity, and maternal ADHD. J Abnorm Psychol. 1995;104(2):334–345. doi: 10.1037/0021-843X.104.2.334
   PubMed Web of Science ®Google Scholar
• Mannisto PT, Kaakkola S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev. 1999;51(4):593–628.
   PubMed Web of Science ®Google Scholar
• Weinshilboum RM, Raymond FA. Inheritance of low erythrocyte catechol-o-methyltransferase activity in man. Am J Hum Genet. 1977;29(2):125–135.
   Web of Science ®Google Scholar
• Lachman HM, Papolos DF, Saito T, et al. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics. 1996;6(3):243–250. doi: 10.1097/00008571-199606000-00007
   PubMedGoogle Scholar
• Du Paul GJ, Power TJ, Anastopoulos AD. ADHD rating scale-IV:checklists, norms, and clinical interpretations. New York: Guilford Press; 1998.
   Google Scholar
• Guy W. ECDU assessment manual for psychopharmacology, revised. Bethesda (MD): US Department of Health, Education and Welfare; 1976.
   Google Scholar
• Kaufman J, Birmaher B, Brent D, et al. Schedule for affective disorders and schizophrenia for school-Age children-present and lifetime version (K-SADSPL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36(7):980–988. doi: 10.1097/00004583-199707000-00021
   PubMed Web of Science ®Google Scholar
• Kemner JE, Starr HL, Ciccone PE, et al. Outcomes of OROS methylphenidate compared with atomoxetine in children with ADHD: a multicenter, randomized prospective study. Adv Ther. 2005;22(5):498–512. doi: 10.1007/BF02849870
   PubMed Web of Science ®Google Scholar
• Gokler B, Unal F, Pehlivanturk B, et al. Reliability and validity of schedule for affective disorders and schizophrenia for school age children present and lifetime version – Turkish version (K-SADSPL-T). Turk J Child Adolesc Ment Health. 2004;11(3):109–116. (Turkish).
   Google Scholar
• Wechsler D. WISC-R Manual for the Wechsler intelligence scale for children – revised. New York: Published by Psychological Corporation; 1974.
   Google Scholar
• Savasir I, Sahin N. Manual for the Wechsler intelligence scale for children – revised (WISC-R). Ankara, (Turkish): Published by Turkish Psychology Association Publication; 1995.
   Google Scholar
• Kotler M, Manor II, Sever Y, et al. Failure to replicate an excess of the long dopamine D4 exon III repeat polymorphism in ADHD in a family-based study. Am J Med Genet (Neuropsychiatric Genetics). 2000;96:278–281. doi: 10.1002/1096-8628(20000612)96:3<278::AID-AJMG8>3.0.CO;2-R
   Web of Science ®Google Scholar
• Eisenberg J, Mei-Tal GI, Steinberg A, et al. Haplotype relative risk study of Catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity Val allele With ADHD impulsive-hyperactive phenotype. Am J Med Genet (Neuropsychiatric Genetics). 1999;88:497–502. doi: 10.1002/(SICI)1096-8628(19991015)88:5<497::AID-AJMG12>3.0.CO;2-F
   PubMed Web of Science ®Google Scholar
• Hamarman S, Fossella J, Ulger C, et al. Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with attention deficit hyperactivity disorder: a pharmacogenetic study. J Child Adolesc Psychopharmacol. 2004;14(4):564–574. doi: 10.1089/cap.2004.14.564
   Web of Science ®Google Scholar
• Gorlick MA, Worthy DA, Knopik VS, et al. DRD4 long allele carriers show heightened attention to high-priority items relative to low-priority items. J Cogn Neurosci. 2015 Mar;27(3):509–521. doi:10.1162/jocn_a_00724.
   Web of Science ®Google Scholar
• Ji HS, Paik KC, Park WS, et al. No association between the response to methylphenidate and DRD4 gene polymorphism in Korean attention deficit hyperactivity disorder: a case control study. Clin Psychopharmacol Neurosci. 2013;11(1):13–17. doi: 10.9758/cpn.2013.11.1.13
   Web of Science ®Google Scholar
• Winsberg BG, Comings DE. Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. J Am Acad Child Adolesc Psychiatry. 1999;38:1474–1477. doi: 10.1097/00004583-199912000-00006
   PubMed Web of Science ®Google Scholar
• Lacerda-Pinheiro SF, Pinheiro Junior RF, Pereira de Lima MA, et al. Are there depression and anxiety genetic markers and mutations? A systematic review. J Affect Disord. 2014 Oct;168:387–398. doi:10.1016/j.jad.2014.07.016.
   Web of Science ®Google Scholar
• Holmes J, Payton A, Barrett J, et al. Association of DRD4 in children with ADHD and comorbid conduct problems. Am J Med Genet Part A. 2002;114(2):150–153. doi: 10.1002/ajmg.10149
   Web of Science ®Google Scholar
• Eisenberg J, Zohar A, Mei-Tal G, et al. A haplotype relative risk study of the dopamine D4 receptor (DRD4) exon III repeat polymorphism and attention deficit hyperactivity disorder (ADHD). Am J Med Genet Part A. 2000;96(3):258–261. doi: 10.1002/1096-8628(20000612)96:3<258::AID-AJMG4>3.0.CO;2-8
   Web of Science ®Google Scholar
• Hawi Z, McCarron M, Kirley A, et al. No association of the dopamine DRD4 receptor (DRD4) gene polymorphism with attention deficit hyperactivity disorder (ADHD) in the Irish population. Am J Med Genet Part A. 2000;96(3):268–272. doi: 10.1002/1096-8628(20000612)96:3<268::AID-AJMG6>3.0.CO;2-#
   Web of Science ®Google Scholar
• Hong SB, Zalesky A, Park S, et al. COMT genotype affects brain white matter pathways in attention-deficit/hyperactivity disorder. Hum Brain Mapp. 2015 Jan;36(1):367–377. doi:10.1002/hbm.22634.
   Web of Science ®Google Scholar
• Kabukcu Basay B, Buber A, Basay O, et al. White matter alterations related to attention-deficit hyperactivity disorder and COMT val(158)met polymorphism: children with valine homozygote attention-deficit hyperactivity disorder have altered white matter connectivity in the right cingulum (cingulate gyrus). Neuropsychiatr Dis Treat. 2016 Apr 21;12:969–981. doi:10.2147/NDT.S104450.
   Web of Science ®Google Scholar
• Yatsuga C, Toyohisa D, Fujisawa TX, et al. No association between catechol-O-methyltransferase (COMT) genotype and attention deficit hyperactivity disorder (ADHD) in Japanese children. Brain and Development. 2014;36:620–625. doi: 10.1016/j.braindev.2013.08.006
   Web of Science ®Google Scholar
• Tahir E, Yazgan Y, Cirakoglu B, et al. Association and linkage of DRD4 and DRD5 with attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Mol Psychiatry. 2000;5(4):396–404. doi: 10.1038/sj.mp.4000744
   Web of Science ®Google Scholar
• McGough J, McCracken J, Loo SK, et al. A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2009;48:1155–1164. doi: 10.1097/CHI.0b013e3181bc72e3
   PubMed Web of Science ®Google Scholar
• Caspi A, Langley K, Milne B, et al. A replicated molecular genetic basis for subtyping antisocial behavior in children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2008;65:203–210. doi: 10.1001/archgenpsychiatry.2007.24
   PubMed Web of Science ®Google Scholar
• Lee YH, Song GG. BDNF 196 G/A and COMT Val158Met polymorphisms and susceptibility to ADHD: a meta-analysis. J Atten Disord. 2015 Feb 17: pii. doi:1087054715570389.
   Google Scholar